Slaughter and May and Linklaters have advised on the acquisition of RMC, the concrete maker, by cement producer CEMEX for £2.3bn. Slaughters head of corporate Christopher Saul led the team advising CEMEX, with Linklaters head of corporate David Cheyne advising RMC. Skadden Arps Slate Meagher & Flom advised CEMEX on US issues.
Corporate partner Charles Mayo led the Simmons & Simmons team advising PA Consulting, the management, systems and technology consulting firm, on the sale of its interest in drug delivery and technology company Meridica to pharmaceutical giant Pfizer for $125m (£70m). Allen & Overy corporate partner Ian Stanley acted for Pfizer.
